SCHEMBL3338050

SCHEMBL3338050

O=C1OCC2=C1C(c1cccc(O)c1)NC(=S)N2

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DHFR P00374 1/20 0.52
GUSB P08236 1/20 0.46
BRD4 O60885 1/20 0.43
ALDH1A1 P00352 5/20 0.43
MEN1 O00255 4/20 0.43
KMT2A Q03164 4/20 0.43
GAA P10253 2/20 0.40
KDM4E B2RXH2 2/20 0.39
ABCC9 O60706 1/20 0.38
ABCC8 Q09428 1/20 0.38
KCNJ11 Q14654 1/20 0.38
KCNJ8 Q15842 1/20 0.38
KIF11 P52732 4/20 0.38
POLB P06746 1/20 0.36
CACNA1C Q13936 1/20 0.36
TRPA1 O75762 1/20 0.36
ALOX15 P16050 1/20 0.35
MAPK1 P28482 1/20 0.35
HSD17B10 Q99714 1/20 0.35
MAPT P10636 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3338330 0.88 DHFR (0.50) DHFRGUSBALDH1A1MEN1KMT2A
SCHEMBL13425478 0.87 MEN1 (0.55) DHFRBRD4ALDH1A1MEN1KMT2A
SCHEMBL13302814 0.84 ALDH1A1 (0.59) DHFRBRD4ALDH1A1MEN1KMT2A
SCHEMBL3344481 0.80 DHFR (0.52) DHFRGUSBALDH1A1MEN1KMT2A
(S)-Enastron SCHEMBL5177968 0.79 ALDH1A1 (0.72) DHFRGUSBALDH1A1MEN1KMT2A
SCHEMBL9701173 0.78 DHFR (0.62) DHFRGUSBALDH1A1GAAKDM4E
SCHEMBL3343387 0.78 DHFR (0.50) DHFRGUSBALDH1A1MEN1KMT2A
SCHEMBL13302762 0.77 DHFR (0.52) DHFRGUSBALDH1A1MEN1KMT2A
Dimethylenastron SCHEMBL5178439 0.77 ALDH1A1 (0.65) DHFRGUSBALDH1A1MEN1KMT2A
SCHEMBL13426046 0.74 KIF11 (0.46) DHFRBRD4ALDH1A1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100152206-A1 Bicyclic Dihydropyrimidines and Uses Thereof PRESIDENT AND FELLOWS OF HARVARD COLLEGE 2010-06-17 US disclosed
US-20100152206-A1 Bicyclic Dihydropyrimidines and Uses Thereof PRESIDENT AND FELLOWS OF HARVARD COLLEGE 2010-06-17 US disclosed
US-20100152206-A1 Bicyclic Dihydropyrimidines and Uses Thereof PRESIDENT AND FELLOWS OF HARVARD COLLEGE 2010-06-17 US disclosed
WO-2006074293-A2 BICYCLIC DIHYDROPYRIMIDINES AS EG5 INHIBITORS PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2006-07-13 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100152206-A1 Bicyclic Dihydropyrimidines and Uses Thereof KIF5A, KIF5C, KIF5B DHFR 45/4885GUSB 2340/4885BRD4 887/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.